Cafepharma | Pharmaceutical Sales, Medical Sales, Lab Sales

Cafepharma Today

November 29 2023 - FDA names chief scientist Bumpus as Woodcock’s successor

FDA names chief scientist Bumpus as Woodcock’s successor
FDA launches probe of malignancies linked to CAR-T therapies
FDA kicks off review of Karuna’s schizophrenia drug KarXT
Lilly puts potential $660M on the line for protein-protein interaction blockers
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Catalent delays quarterly filing with SEC on $700 mln impairment charge

Reuters

Tuesday, November 14, 2023 - 11:18am

tags:

Catalent, SEC, M&A

Harnessing Social Media for Clinical Trial Recruitment

BioSpace

Tuesday, November 14, 2023 - 10:59am

tags:

clinical trials, clinical trial recruitment, social media

AstraZeneca Bid to Expand Imfinzi’s NSCLC Label Hit with Phase III Flop

BioSpace

Tuesday, November 14, 2023 - 10:55am

tags:

AstraZeneca, Imfinzi, clinical trials, non-small cell lung cancer

Bayer to withdraw follicular lymphoma therapy after trial failure

Clinical Trials Arena

Tuesday, November 14, 2023 - 9:37am

tags:

Bayer, Aliqopa, relapsed follicular lymphoma, clinical trials

Hepatitis B drug developers chart slow progress forward, just like hep C before it

Fierce Biotech

Tuesday, November 14, 2023 - 9:35am

tags:

hepatitis B, hepatitis C, drug development, Assembly Biosciences, GSK, Aligos Therapeutics

Merck-backed VectorY Therapeutics raises $138M series A to push forward ALS program

Fierce Biotech

Tuesday, November 14, 2023 - 9:28am

tags:

VectorY Therapeutics, funding, ALS, Merck

Viatris and Theravance report data from COPD treatment trial

Clinical Trials Arena

Tuesday, November 14, 2023 - 9:24am

tags:

Viatris, Theravance, clinical trials, Yupelri, COPD

Autifony swings $770.5m deal with Jazz for CNS drugs

Pharmaphorum

Tuesday, November 14, 2023 - 9:22am

tags:

Autifony, Jazz Pharma, neurological disorders

Ipsen, eyeing approval, reveals mixed liver disease data on challenger to Intercept and CymaBay

Fierce Biotech

Tuesday, November 14, 2023 - 9:20am

tags:

Ipsen, Genfit, elafibranor, liver disease, Intercept Pharma, CymaBay Therapeutics

Capturing COVID: Biopharma through the lens during the pandemic

Fierce Pharma

Monday, November 13, 2023 - 11:05pm

tags:

pharma industry, COVID-19, pandemic

FDA Deems Recall of Stolen Medtronic Laryngoscopes as Class I

Medical Devices and Diagnostics Industry

Monday, November 13, 2023 - 11:04pm

tags:

Medtech, Medtronic, laryngoscopes, product recalls, device recalls, FDA

Michigan Senate Votes to Repeal Pharmaceutical Immunity From Product Liability Suits

JD Supra

Monday, November 13, 2023 - 11:01pm

tags:

legislation, legal, Michigan, product liability

Study suggests Covid rebound is far more common with Paxlovid than without

Stat

Monday, November 13, 2023 - 10:57pm

tags:

Pfizer, Paxlovid, COVID-19, antivirals

Novo Nordisk says Wegovy can help heart disease patients—and not just because it produces weight loss

Fierce Pharma

Monday, November 13, 2023 - 12:08pm

tags:

Novo Nordisk, Wegovy, heart disease, cardiovascular disease, clinical trials

Lilly, UCB-Backed ViaNautis Scores $25M for Genetic Nanomedicines

BioSpace

Monday, November 13, 2023 - 11:58am

tags:

ViaNautis Bio, Eli Lilly, genetic nanomedicine, UCB Pharma, funding

Novartis pays Legend $100M upfront to give solid tumor CAR-T the T-Charge treatment

Fierce Biotech

Monday, November 13, 2023 - 11:55am

tags:

Novartis, Legend Biotech, CAR-T, T-Charge, solid tumors

Half a year later, Teva's 'pivot to growth' strategy appears to be bearing fruit

Fierce Pharma

Monday, November 13, 2023 - 11:52am

tags:

Teva Pharmaceutical, earnings

Medtronic reveals 12-month study data for DTM SCS therapy

Clinical Trials Arena

Monday, November 13, 2023 - 11:49am

tags:

Medtech, Medtronic, Spinal Cord Stimulation, chronic back pain, DTM spinal cord stimulation

Cell & Gene Therapy Space Gears Up for First CRISPR Approval

BioSpace

Monday, November 13, 2023 - 11:48am

tags:

CRISPR, gene therapy, cell therapy, sickle cell disease, exa-cel, Vertex Pharmaceuticals, CRISPR Therapeutics

5 of the best paid biopharma CEOs

PharmaVoice

Monday, November 13, 2023 - 10:10am

tags:

Pharma CEOs, executive compensation, Sarepta Therapeutics, Royalty Pharma, Seagen, Zentalis, Pfizer

Pages

Latest CP Wire Articles

First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study

Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth

Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Sapio Sciences launches new drug discovery platform

Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics

Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility

Eastman introduces new excipient to formulate poorly soluble API

Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more

PharmaBlock Receives 2023 ACS CMO Excellence in Green Chemistry Award

Latest Pharmagather Articles

Drug Channels News Roundup, November 2023: My $0.02 on Express Scripts’ Cost-Based Pricing, Mark Cuban vs. PBMs, Dual-WAC Strategies, Pharmacy Shakeout, and Adam vs. Rocky

Drug Channels

Simplify and Accelerate Benefits Verification with a Fully Integrated, Adaptable Platform

Drug Channels

Medicare Part D in 2024: Mapping Large Chains' Position in 2024’s Preferred Pharmacy Networks

Drug Channels

Drug Channels Outlook 2024 (NEW Live Video Webinar)

Drug Channels

Four Trends That Are Shaping the Future of Market Access

Drug Channels

FDA’s OPDP Issues Two New Untitled Letters

eye on fda

Vertical Integration Lessons: The Economics and Strategies of Hospital-Owned Specialty Pharmacies

Drug Channels

Is Your Hub Partner Missing the Therapeutic Area Expertise You Need?

Drug Channels

Drug Channels News Roundup, October 2023: CVS & Humira Biosimilars, GLP-1 G2N Bubble, 340B Abuses, Rite Aid's Endgame, Mark Cuban Update, and an Epic Meetup

Drug Channels